Conduit Pharmaceuticals Inc.
CDT
$0.6201
-$0.16-20.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 62.76% | -20.03% | -51.55% | -1,549.80% | -91.83% |
| Total Depreciation and Amortization | 8,940.00% | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 449.65% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -109.52% | -26.09% | 134.17% | 159.08% | 34.36% |
| Change in Net Operating Assets | -227.24% | 215.81% | 399.00% | 92.51% | -3,542.31% |
| Cash from Operations | -90.75% | -32.12% | 35.81% | 50.93% | -816.60% |
| Capital Expenditure | 100.00% | -310.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -37.96% | 164.02% | -- | -- | 641.79% |
| Cash from Investing | -11.46% | 142.86% | -- | -- | 641.79% |
| Total Debt Issued | -14.92% | -- | -- | -- | -189.96% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 338,900.00% | -99.12% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -99.05% |
| Cash from Financing | 141.40% | 1,443.36% | -- | -- | -104.54% |
| Foreign Exchange rate Adjustments | -90.91% | 1,200.00% | 96.30% | -108.88% | 2,863.64% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 426.35% | 90.89% | 31.84% | 46.01% | -151.09% |